Skip to main content
. 2022 Apr 8;35(3):260–266. doi: 10.20524/aog.2022.0713

Figure 1.

Figure 1

Volume of Pneumocystis jiroveci pneumonia (PCP) admissions among inflammatory bowel disease (IBD) patients from 2002-2017. Linear regression evaluating change in annual admission rates for PCP among patients with IBD, showing a statistically significant positive correlation with an average increase of 5.02 admissions annually